On days 1 and 8, patients received either oral ivermectin or 0.5% malathion lotion and the corresponding placebo tablets or lotion. On day 15, participants with persistent infestation were ...
A Justice Department attorney told the panel the FDA “has to be able to make these kinds of public safety statements” about risky uses of drugs, an argument the judges rejected Friday. Writing for the ...